Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
Chief Executive Officer
Zoetis
Kristin Peck is Chief Executive Officer of Zoetis, the world’s leading animal health company and a member of the Fortune 500. Ms. Peck is also a member of the Zoetis Board of Directors.
Prior to becoming CEO in 2020, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis. She helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company.
Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc., and as a member of Pfizer’s Executive Leadership Team. Previously, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O’Connor Group and J.P. Morgan.
Ms. Peck serves on the Board of BlackRock and is a member of the Business Roundtable and a Board member of Catalyst, a global non-profit that helps companies accelerate women into leadership. In addition, she serves on the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. Named by Barron’s as one of the top CEOs in 2022, and by Fortune as a 2020 Businessperson of the Year, Ms. Peck has been recognized for her leadership and Zoetis’ strong performance in challenging times.
Ms. Peck holds a bachelor’s degree from Georgetown University and an MBA from Columbia Business School.
